An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy

KX Li, MJ Ji, HJ Sun - Gene, 2021 - Elsevier
As one of the most common complications of diabetes, nephropathy develops in
approximately 40% of diabetic individuals. Although end stage kidney disease is known as …

DR region of NKAα1 is a target to ameliorate hepatic lipid metabolism disturbance in obese mice

HJ Sun, JX Tan, XD Shan, ZC Wang, ZY Wu, JS Bian… - Metabolism, 2023 - Elsevier
Abstract Background Na+/K+-ATPase (NKA), an ion pumping enzyme ubiquitously
expressed in various cells, is critically involved in cellular ion homeostasis and signal …

Targeting the Na+/K+ ATPase DR-region with DR-Ab improves doxorubicin-induced cardiotoxicity

B Leng, L Deng, J Tan, WT Lee, CR Cao… - Free Radical Biology …, 2023 - Elsevier
Doxorubicin (DOX) is a potent chemotherapeutic drug for various cancers. Yet, the
cardiotoxic side effects limit its application in clinical uses, in which ferroptosis serves as a …

Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities

NM Sergienko, DG Donner, LMD Delbridge… - Cellular …, 2022 - Elsevier
Protein phosphatases have emerged as critical regulators of phosphoprotein homeostasis in
settings of health and disease. Protein phosphatase 2A (PP2A) encompasses a large …

Anti–Na+/K+-ATPase immunotherapy ameliorates α-synuclein pathology through activation of Na+/K+-ATPase α1–dependent autophagy

L Cao, S Xiong, Z Wu, L Ding, Y Zhou, H Sun… - Science …, 2021 - science.org
Na+/K+-ATPase (NKA) plays important roles in maintaining cellular homeostasis.
Conversely, reduced NKA activity has been reported in aging and neurodegenerative …

[HTML][HTML] Induction of caveolin-3/eNOS complex by nitroxyl (HNO) ameliorates diabetic cardiomyopathy

HJ Sun, SP Xiong, ZY Wu, L Cao, MY Zhu, PK Moore… - Redox Biology, 2020 - Elsevier
Abstract Nitroxyl (HNO), one-electron reduced and protonated sibling of nitric oxide (NO), is
a potential regulator of cardiovascular functions. It produces positive inotropic, lusitropic …

Stimulation of Na+/K+‐ATPase with an Antibody against Its 4th Extracellular Region Attenuates Angiotensin II‐Induced H9c2 Cardiomyocyte Hypertrophy via an AMPK/SIRT3 …

S Xiong, HJ Sun, L Cao, M Zhu, T Liu… - … medicine and cellular …, 2019 - Wiley Online Library
Activation of the renin‐angiotensin system (RAS) contributes to the pathogenesis of
cardiovascular diseases. Sodium potassium ATPase (NKA) expression and activity are often …

Targeting NKAα1 to treat Parkinson's disease through inhibition of mitophagy-dependent ferroptosis

X Zhang, G Li, H Chen, XW Nie, JS Bian - Free Radical Biology and …, 2024 - Elsevier
Dysfunction of the Na+/K+-ATPase (NKA) has been documented in various
neurodegenerative diseases, yet the specific role of NKAα1 in Parkinson's disease (PD) …

Anti–Na+/K+-ATPase DR antibody attenuates UUO-induced renal fibrosis through inhibition of Na+/K+-ATPase α1–dependent HMGB1 release

J Zheng, P Lan, M Li, M Kang, M Xun, X Ma… - International …, 2023 - Elsevier
Abstract Reduced Na+/K+-ATPase (NKA) activity and NKAα1 expression are engaged in the
pathologies of renal diseases. NKA-mediated Src activation is not the only reason for NKA …

Regulation of Na+-K+-ATPase leads to disturbances of isoproterenol-induced cardiac dysfunction via interference of Ca2+-dependent cardiac metabolism

X Yan, M Li, P Lan, M Xun, Y Zhang, J Shi… - Clinical …, 2024 - portlandpress.com
Abstract Reductions in Na+-K+-ATPase (NKA) activity and expression are often observed in
the progress of various reason-induced heart failure (HF). However, NKA α1 mutation or …